DOI QR코드

DOI QR Code

Disseminated Postnatal Cytomegalovirus Infection in a Preterm Neonate: Autopsy Case Report

  • Kim, Ka-Young (Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine) ;
  • Kim, Ee-Kyung (Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine) ;
  • Park, Sung-Hye (Department of Pathology, Seoul National University College of Medicine) ;
  • Kim, Yoo Jinie (Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine) ;
  • Shin, Seung-Han (Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine) ;
  • Kim, Han-Suk (Division of Neonatology, Department of Pediatrics, Seoul National University College of Medicine)
  • Received : 2021.01.25
  • Accepted : 2021.04.22
  • Published : 2021.05.31

Abstract

Treatment guidelines for postnatal cytomegalovirus (pCMV) infection in preterm have not been established yet. Neutropenia, thrombocytopenia, hepatitis, colitis, and sepsis-like disease are among the clinical manifestations, which range from moderate to serious. We present a case of autopsy diagnosed as pCMV infection in a premature infant delivered at gestational age of 24 weeks and 5 days. On the 7th and 14th days of birth, urinary CMV polymerase chain reaction samples were negative, ruling out congenital CMV infection. However, autopsy examination revealed that the patient had disseminated pCMV infection. CMV inclusion bodies were found in the majority of tissues, including the lung, liver, pancreas, breast, kidney, and adrenal gland, but not the placenta. The thymus exhibited significant cortical atrophy and T-cell immunodeficiency, possibly induced by dexamethasone treatment for bronchopulmonary dysplasia or by pCMV infection itself. If dexamethasone treatment is extended or high doses are considered, it may be beneficial to test the CMV infection status to prevent aggravation of infection. This case demonstrates that, despite the low prevalence, pCMV infection should be considered a differential diagnosis in preterm if other conditions or etiology cannot justify clinical deterioration.

Keywords

References

  1. Bialas KM, Swamy GK, Permar SR. Perinatal cytomegalovirus infections: epidemiology, prevention, and treatment. NeoReviews 2015;16:e231-5. https://doi.org/10.1542/neo.16-4-e231
  2. Choi SR, Kim KR, Kim DS, Kang JM, Kim SJ, Kim JM, et al. Changes in cytomegalovirus seroprevalence in Korea for 21 years: a single center study. Pediatr Infect Vaccine 2018;25:123-31. https://doi.org/10.14776/piv.2018.25.e8
  3. Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T, Alain S, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis 2017;17: e177-88. https://doi.org/10.1016/S1473-3099(17)30143-3
  4. Yasuda A, Kimura H, Hayakawa M, Ohshiro M, Kato Y, Matsuura O, et al. Evaluation of cytomegalovirus infections transmitted via breast milk in preterm infants with a real-time polymerase chain reaction assay. Pediatrics 2003;111(6 Pt 1):1333-6. https://doi.org/10.1542/peds.111.6.1333
  5. Stehel EK, Sanchez PJ. Cytomegalovirus infection in the fetus and neonate. NeoReviews 2005;6:e38-45. https://doi.org/10.1542/neo.6-1-e38
  6. Coclite E, Di Natale C, Nigro G. Congenital and perinatal cytomegalovirus lung infection. J Matern Fetal Neonatal Med 2013; 26:1671-5. https://doi.org/10.3109/14767058.2013.794207
  7. Hamprecht K, Goelz R. Postnatal cytomegalovirus infection through human milk in preterm infants: transmission, clinical presentation, and prevention. Clin Perinatol 2017;44:121-30. https://doi.org/10.1016/j.clp.2016.11.012
  8. Kelly MS, Benjamin DK, Puopolo KM, Laughon MM, Clark RH, Mukhopadhyay S, et al. Postnatal cytomegalovirus infection and the risk for bronchopulmonary dysplasia. JAMA Pediatr 2015;169:e153785. https://doi.org/10.1001/jamapediatrics.2015.3785
  9. Wesolowska A, Sinkiewicz-Darol E, Barbarska O, Bernatowicz-Lojko U, Borszewska-Kornacka MK, van Goudoever JB. Innovative techniques of processing human milk to preserve key components. Nutrients 2019;11:1169. https://doi.org/10.3390/nu11051169
  10. Klotz D, Jansen S, Gebauer C, Fuchs H. Handling of breast milk by neonatal units: large differences in current practices and beliefs. Front Pediatr 2018;6:235. https://doi.org/10.3389/fped.2018.00235
  11. Vamvakas EC. Is white blood cell reduction equivalent to anti-body screening in preventing transmission of cytomegalovirus by transfusion?: a review of the literature and meta-analysis. Transfus Med Rev 2005;19:181-99. https://doi.org/10.1016/j.tmrv.2005.02.002
  12. Kim AR, Lee YK, Kim KA, Chu YK, Baik BY, Kim ES, et al. Transfusion-related cytomegalovirus infection among very low birth weight infants in an endemic area. J Korean Med Sci 2006;21:5-10. https://doi.org/10.3346/jkms.2006.21.1.5
  13. Fischer C, Meylan P, Bickle Graz M, Gudinchet F, Vaudaux B, Berger C, et al. Severe postnatally acquired cytomegalovirus infection presenting with colitis, pneumonitis and sepsis-like syndrome in an extremely low birthweight infant. Neonatology 2010;97:339-45. https://doi.org/10.1159/000260137
  14. Stoll BJ, Temprosa M, Tyson JE, Papile LA, Wright LL, Bauer CR, et al. Dexamethasone therapy increases infection in very low birth weight infants. Pediatrics 1999;104:e63. https://doi.org/10.1542/peds.104.5.e63
  15. Hussar P, Tokin I, Filimonova G, Hussar U. Dexamethasone-induced T-lymphocyte apoptosis in different lymphoid organs. Pap Anthropol 2011;20:117-27. https://doi.org/10.12697/poa.2011.20.13
  16. Cicin-Sain L, Brien JD, Uhrlaub JL, Drabig A, Marandu TF, Nikolich-Zugich J. Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging. PLoS Pathog 2012;8:e1002849. https://doi.org/10.1371/journal.ppat.1002849